National Organization for Rare Disorders, Inc.PhenylketonuriaImportant It is possible that the main title of the report Phenylketonuria is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
Synonyms- Classical Phenylketonuria
- Hyperphenylalanemia
- Phenylalanine Hydroxylase Deficiency
- Phenylalaninemia
- PKU
Disorder SubdivisionsGeneral DiscussionPhenylketonuria (PKU) is an inborn error of metabolism that is detectable during the first days of life with appropriate blood testing (e.g., during routine neonatal screening). PKU is characterized by absence or deficiency of an enzyme (phenylalanine hydroxylase) that is responsible for processing the essential amino acid phenylalanine. (Amino acids, the chemical building blocks of proteins, are essential for proper growth and development.) With normal enzymatic activity, phenylalanine is converted to another amino acid (tyrosine), which is then utilized by the body. However, when the phenylalanine hydroxylase enzyme is absent or deficient, phenylalanine abnormally accumulates in the blood and is toxic to brain tissue.
Symptoms associated with PKU are typically absent in newborns. Affected infants may be abnormally drowsy and listless (lethargic) and have difficulties feeding. In addition, untreated infants with PKU tend to have unusually light eyes, skin, and hair (light pigmentation) and may develop a rash that appears similar to eczema, an inflammatory skin condition that may be characterized by itching, redness, and blistering in affected areas.
Without treatment, most infants with PKU develop mental retardation that is typically severe. Those with untreated PKU may also develop additional neurologic symptoms, such as episodes of uncontrolled electrical activity in the brain (seizures), abnormally increased activity (hyperactivity), poor coordination and a clumsy manner of walking (gait), abnormal posturing, aggressive behavior, or psychiatric disturbances. Additional symptoms and findings may include nausea, vomiting, and a musty or "mousy" body odor due to the presence of a by-product of phenylalanine (phenylacetic acid) in the urine and sweat.
To prevent mental retardation, treatment consists of a carefully controlled, phenylalanine-restricted diet beginning during the first days or weeks of life. Most experts suggest that a phenylalanine-restricted diet should be lifelong in persons with classical PKU. Classical PKU refers to persons with 2 severe mutations of the phenylalanine hydroxylase gene. . ResourcesMarch of Dimes Birth Defects Foundation 1275 Mamaroneck Avenue White Plains, NY 10605 Tel: (914)997-4488 Fax: (914)997-4763 Tel: (888)663-4637 Email: Askus@marchofdimes.com Internet: http://www.marchofdimes.com
National PKU News 6869 Woodlawn Avenue NE #116 Seattle, WA 98115-5469 Tel: (206)525-8140 Fax: (206)525-5023 Email: schuett@pkunews.org Internet: http://www.pkunews.org
Children's PKU Network 3790 Via De La Valle, Ste 120 Del Mar, CA 92014 United States Tel: (858)509-0767 Fax: (858)509-0768 Tel: (800)377-6677 Email: pkunetwork@aol.com Internet: http://www.pkunetwork.org/
National Institute of Mental Retardation York University Kinsmen NIMR Building 4700 Keele Street North York, Toronto Ontario, M3J 1P3 Canada Tel: 4166619611
Phenylalanine Hydroxylase Locus Knowledgebase (PAHdb) McGill Univeristy Health Center Montreal Children's Hospital DeBelle Laboratory, Room A717 2300 Tupper St. Monteral, Quebec, H3H 1P3 Canada Tel: 5144124417 Fax: 5144124329 Email: pahdb@debelle.mcgill.ca Internet: http://www.pahde.mcgill.ca
NIH/National Institute of Child Health and Human Development 31 Center Dr Building 31, Room 2A32 MSC2425 Bethesda, MD 20892 Tel: (301)496-5133 Fax: (301)496-7101 Internet: http://www.nichd.nih.gov/
Cochrane Cystic Fibrosis and Genetic Disorders Group Institute of Child Health, University of Liverpool Alder Hey Children's NHS Foundation Trust Liverpool, L12 2 AP United Kingdom Tel: +44 (0) 151 252 5696 Fax: +44 (0) 151 252 5456 Email: nikkij@liverpool.ac.uk Internet: http://www.cfgd.cochrane.org/en/index.html
MUMS National Parent-to-Parent Network 150 Custer Court Green Bay, WI 54301-1243 USA Tel: (920)336-5333 Fax: (920)339-0995 Tel: (877)336-5333 Email: mums@netnet.net Internet: http://www.netnet.net/mums/
Belgian Association for Metabolic Diseases (BOKS) Alice Nahonlann 7 Melsele, 9120 Belgium Tel: 3237754839 Email: info@boks.be Internet: http://www.boks.be
Genetic and Rare Diseases (GARD) Information Center PO Box 8126 Gaithersburg, MD 20898-8126 Tel: (301)251-4925 Fax: (301)251-4911 Tel: (888)205-2311 TDD: (888)205-3223 Email: ordr@od.nih.gov Internet: http://rarediseases.info.nih.gov/Default.aspx
Mid-Atlantic Connection for PKU and Allied Disorders, Inc. PO Box 6086 Lancaster, PA 17607-6086 Tel: (717)872-7546 Fax: (717)872-7546 Email: info@macpad.org Internet: http://www.macpad.org
Madisons Foundation PO Box 241956 Los Angeles, CA 90024 Tel: (310)264-0826 Fax: (310)264-4766 Email: getinfo@madisonsfoundation.org Internet: http://www.madisonsfoundation.org
Cook for Love, Inc. 30 Seneca Street Dobbs Ferry, NY 10522 Tel: (914)674-1025 Email: info@cookforlove.org Internet: http://www.cookforlove.org
National PKU Alliance P.O. Box 501 Tomahawk, WI 54487-0501 USA Tel: (715)437-0477 Fax: (715)453-7670 Email: christine.brown@npkua.org Internet: http://www.npkua.org
For a Complete ReportThis is an abstract of a report from the National Organization for Rare Disorders, Inc. ® (NORD). A copy of the complete report can be obtained for a small fee by visiting the NORD website. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational treatments (if available), and references from medical literature. For a full-text version of this topic, see http://www.rarediseases.org/search/rdblist.html The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians. It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder. For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email orphan@rarediseases.org
Last Updated: 5/1/2007 Copyright 1986, 1989, 1990, 1993, 1996, 1997, 1998, 1999, 2000, 2002, 2003, 2004, 2006 National Organization for Rare Disorders, Inc.
| |